This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Citing articles on Web of Science (11)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

KURT IVERSEN, M.D.; FLEMMING RAASCHOU, M.D.

Arch Intern Med. 1948;82(3):251-262.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

IN 1944 MacLagan¹ introduced the thymol turbidity test for diagnosis of diseases of the liver. With this test it should be possible to distinguish between hepatitis, obstructive jaundice and hepatic cancer. The thymol turbidity test has since been analyzed by various investigators (Watson and Rappaport,² Hawkinson and Giebenhain, Shank and Hoagland,³ Kunkel and Hoagland,⁴ Lehmann,⁵ Maizels,⁶ Havens and Marck⁷ and Brante⁸). In conformity with MacLagan these investigators observed the reaction to be positive in about 90 per cent of cases of acute hepatitis and as a rule positive in chronic hepatitis, whereas it was rarely observed to be positive in cases of obstruction of the bile duct and hepatic cancer.

The thymol turbidity test is a flocculation reaction on certain plasma proteins. The flocculation occurs by means of a saturated thymol solution at pH 7.8. The turbidity is read in Pulfrich's photometer against a barbital buffer solution with thymol. The . . . [Full Text PDF of this Article]

Author Affiliations
COPENHAGEN, DENMARK

From the Department of Infectious Diseases, Frederiksberg Hospital (Physician in Chief N. I. Nissen, M.D.), Copenhagen.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?